ORMDL3 (ORM1-like protein 3) is a conserved, multi-pass transmembrane protein of 153 amino acids that resides in the endoplasmic reticulum (ER) membrane. It functions as a ceramide-sensitive regulatory subunit of the serine palmitoyltransferase (SPT) complex (SPTLC1/SPTLC2/ssSPTa/ORMDL3), the enzyme that catalyzes the first and rate-limiting step in de novo sphingolipid biosynthesis. ORMDL3 acts as a negative regulator of SPT: its N-terminus physically occludes the substrate entry tunnel of SPT, and this inhibitory conformation is stabilized by ceramide binding, thereby implementing a homeostatic negative feedback loop that maintains sphingolipid levels. Structurally resolved by cryo-EM, ORMDL3 has four transmembrane helices and a cytoplasmic N-terminal ceramide-sensing region. The 17q21 locus containing ORMDL3 is the strongest and most replicated genetic risk locus for childhood asthma. Beyond sphingolipid regulation, ORMDL3 has been implicated in ER stress/UPR signaling, ER calcium homeostasis, and autophagy regulation in immune cells, though these may represent downstream consequences of altered sphingolipid metabolism rather than independent molecular functions.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0030148
sphingolipid biosynthetic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: ORMDL3 is a regulatory subunit of the SPT complex that controls the rate-limiting step in sphingolipid de novo biosynthesis. The IBA annotation to sphingolipid biosynthetic process is well supported by the conserved role of ORM/ORMDL family proteins in sphingolipid metabolism from yeast to human (PMID:20182505, PMID:33558761).
Reason: Core function. ORMDL3 is an integral component of the SPT complex and directly regulates sphingolipid biosynthetic flux. This is phylogenetically conserved across the ORM family.
Supporting Evidence:
PMID:20182505
Orm family proteins mediate sphingolipid homeostasis... we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production.
PMID:33558761
the first and rate-limiting step of sphingolipid synthesis is catalyzed by the serine palmitoyltransferase holocomplex, which consists of catalytic components (SPTLC1 and SPTLC2) and regulatory components (ssSPTa and ORMDL3).
|
|
GO:0090156
intracellular sphingolipid homeostasis
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: ORMDL3 implements ceramide-dependent negative feedback on SPT to maintain sphingolipid homeostasis. Ceramide binding to the ORMDL3 N-terminus stabilizes an inhibitory conformation that blocks SPT substrate entry, constituting a homeostatic sensor mechanism (PMID:20182505, PMID:37308477).
Reason: Core function. ORMDL3 is the ceramide-sensing subunit of the SPT complex that provides homeostatic feedback regulation of sphingolipid levels. This is the primary evolved role of the ORM/ORMDL family.
Supporting Evidence:
PMID:20182505
Orm proteins are dynamic negative regulators of serine palmitoyltransferase whose inhibitory activity is dependent on adequate levels of downstream sphingolipids
PMID:37308477
Structural studies indicate that ceramide can induce and lock the N-terminus of ORMDL3 into an inhibitory conformation.
|
|
GO:0017059
serine palmitoyltransferase complex
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: ORMDL3 is a stoichiometric subunit of the SPT complex. The phylogenetic inference is consistent with conserved physical association of ORM/ORMDL proteins with SPT from yeast to human, confirmed by co-IP and cryo-EM structural studies (PMID:20182505, PMID:33558761, PMID:33558762).
Reason: Core localization. Structural and biochemical data confirm ORMDL3 is an integral subunit of the SPT holoenzyme complex.
Supporting Evidence:
PMID:20182505
Immunoprecipitations from HEK293T cells expressing 3×Flag-tagged Ormdl3 led to a prominent Sptlc1 band detected by Western blot (Fig
|
|
GO:0006672
ceramide metabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: ORMDL3 regulates ceramide levels by controlling SPT activity, the rate-limiting step upstream of ceramide synthesis. This IBA annotation is phylogenetically sound, as yeast ORM proteins also regulate ceramide levels (PMID:20182505).
Reason: Ceramide levels are directly controlled by ORMDL3-mediated regulation of SPT. Loss of ORM/ORMDL function leads to elevated ceramide levels in both yeast and human cells.
Supporting Evidence:
PMID:20182505
we found that simultaneous knock-down by RNAi of ORMDL1/2/3 in Hela cells causes an approximately three-fold increase in ceramide levels
|
|
GO:0005789
endoplasmic reticulum membrane
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: ORMDL3 is an ER membrane-resident multi-pass transmembrane protein. This IEA is consistent with experimental data showing ER membrane localization by GFP-tagging (PMID:12093374), immunofluorescence (PMID:19819884), and cryo-EM structures showing ORMDL3 embedded in the membrane within the SPT complex (PMID:33558761, PMID:33558762).
Reason: Correct and well-supported. UniProt annotation from subcellular localization data; multiple experimental lines confirm ER membrane localization.
Supporting Evidence:
PMID:12093374
fusion proteins of enhanced green fluorescent protein and ORMDL (EGFP-ORMDL) appeared predominantly in the perinuclear endoplasmic reticulum (ER) and, to a lesser extent, throughout the extended ER network
|
|
GO:0006665
sphingolipid metabolic process
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: IEA annotation to sphingolipid metabolic process from ARBA. This is correct but broader than the more specific IBA annotations already present (GO:0030148 sphingolipid biosynthetic process, GO:0090156 intracellular sphingolipid homeostasis).
Reason: Correct parent term. Although more specific terms are already annotated via IBA, this broader IEA annotation is not wrong and reflects the general role of ORMDL3 in sphingolipid metabolism.
|
|
GO:0016020
membrane
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Generic membrane annotation from InterPro domain mapping. ORMDL3 is indeed a multi-pass transmembrane protein with four transmembrane helices.
Reason: Correct but very generic. More specific ER membrane annotation is also present. This is an acceptable broad IEA.
|
|
GO:2000303
regulation of ceramide biosynthetic process
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: IEA from ARBA for regulation of ceramide biosynthetic process. This is correct but could be more specific: ORMDL3 is a negative regulator, and the more specific child term GO:1900060 (negative regulation of ceramide biosynthetic process) is already annotated via IMP.
Reason: Correct at the level of specificity typical for IEA. The more precise negative regulation term (GO:1900060) is captured by the IMP annotation from PMID:25691431.
|
|
GO:0005515
protein binding
|
IPI
PMID:20182505 Orm family proteins mediate sphingolipid homeostasis. |
MODIFY |
Summary: Physical interaction between ORMDL3 and SPTLC1 (O15269) demonstrated by co-immunoprecipitation from HEK293T cells expressing 3xFlag-tagged ORMDL3 (PMID:20182505). This interaction is functionally significant as ORMDL3 is a regulatory subunit of the SPT complex.
Reason: The protein binding annotation is uninformative. The interaction with SPTLC1 reflects ORMDL3's role as a subunit of the SPT complex. A more informative annotation would be enzyme inhibitor activity (GO:0004857), reflecting ORMDL3's function as a direct inhibitor of SPT catalytic activity through physical interaction.
Proposed replacements:
enzyme inhibitor activity
Supporting Evidence:
PMID:20182505
Immunoprecipitations from HEK293T cells expressing 3×Flag-tagged Ormdl3 led to a prominent Sptlc1 band detected by Western blot (Fig
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: High-throughput binary protein interactome study (HuRI) reporting many interactions for ORMDL3. Most of these interactions (with AQP6, ARL13B, various GPCRs, channels, etc.) lack functional validation and likely represent the promiscuous detection typical of membrane protein screens. The biologically meaningful interactions are with SPT complex components, not with the diverse set of membrane proteins identified here.
Reason: High-throughput interactome data. The 25+ distinct interactors from this single study include many membrane proteins with no known functional relationship to ORMDL3 (e.g., AQP6, GPR101, GPR152, ROM1). Generic protein binding from HT screens is uninformative for ORMDL3's function.
Supporting Evidence:
PMID:32296183
Here we present a human 'all-by-all' reference interactome map of human binary protein interactions, or 'HuRI'. With approximately 53,000 protein-protein interactions
|
|
GO:0005515
protein binding
|
IPI
PMID:33558761 Structural insights into the regulation of human serine palm... |
MODIFY |
Summary: Cryo-EM structure of the human SPT-ORMDL3 complex at 2.6 Angstrom resolution demonstrates direct physical contact between ORMDL3 and SPTLC1 (O15269) within the SPT holoenzyme (PMID:33558761). This is structurally validated interaction, not mere binding.
Reason: The protein binding term is uninformative. The structural data reveal that ORMDL3 physically occludes the SPT substrate entry tunnel, acting as an enzyme inhibitor. This should be annotated as enzyme inhibitor activity.
Proposed replacements:
enzyme inhibitor activity
Supporting Evidence:
PMID:33558761
ORMDL3 blocks the tunnel and competes with substrate binding through its amino terminus
|
|
GO:0005515
protein binding
|
IPI
PMID:33558762 Structural insights into the assembly and substrate selectiv... |
MODIFY |
Summary: Second independent cryo-EM structure study of the SPT-ORMDL3 complex (Li et al. 2021) confirming physical interaction between ORMDL3 and SPTLC1 within the SPT holoenzyme at 3.2 Angstrom resolution.
Reason: As with PMID:33558761, the generic protein binding annotation is uninformative. The structural interaction represents enzyme inhibitor activity within the SPT complex.
Proposed replacements:
enzyme inhibitor activity
Supporting Evidence:
PMID:33558762
ORMDL3 is located in the center of the complex, serving to stabilize the SPT assembly
|
|
GO:0005783
endoplasmic reticulum
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: IDA annotation from HPA immunofluorescence data. ORMDL3 localizes to the ER, consistent with its known ER membrane topology and function as an SPT complex subunit.
Reason: Correct. ER localization is the primary subcellular localization of ORMDL3, confirmed by multiple methods including GFP-fusion (PMID:12093374), immunofluorescence (PMID:19819884), and cryo-EM structures.
|
|
GO:0002903
negative regulation of B cell apoptotic process
|
IMP
PMID:28747345 ORMDL3 Facilitates the Survival of Splenic B Cells via an AT... |
KEEP AS NON CORE |
Summary: Dang et al. 2017 showed that Ormdl3 knockout mice have increased apoptosis of splenic B cells, and that ORMDL3 facilitates B cell survival via ATF6-Beclin1 autophagy pathway. The annotation reflects a downstream phenotypic consequence in the immune system.
Reason: This is a pleiotropic downstream effect likely mediated through ORMDL3's primary role in sphingolipid/ER stress regulation, rather than a direct molecular function of ORMDL3 in anti-apoptotic signaling. B cell survival effects are likely secondary to altered sphingolipid metabolism and ER stress responses.
Supporting Evidence:
PMID:28747345
silencing Ormdl3 in vivo significantly decreased the proportions of mature B lymphocytes and transitional 2B cells in spleen... knockdown of Ormdl3 augmented the apoptosis of total splenic cells and splenic CD19+ B cells
|
|
GO:0010508
positive regulation of autophagy
|
IDA
PMID:28747345 ORMDL3 Facilitates the Survival of Splenic B Cells via an AT... |
KEEP AS NON CORE |
Summary: Dang et al. 2017 showed ORMDL3 promotes autophagy via the ATF6-Beclin1 pathway. ORMDL3 overexpression increased Beclin1 and LC3-II expression and increased autophagy marker levels. This likely reflects secondary effects of ORMDL3's role in ER stress modulation.
Reason: Autophagy regulation by ORMDL3 appears to be an indirect consequence of its effects on ER stress/UPR signaling (ATF6 activation), which itself may stem from altered sphingolipid metabolism. This is not a core molecular function.
Supporting Evidence:
PMID:28747345
ORMDL3 potentially mediates the autophagy via the ATF 6-Beclin1 autophagy pathway, and it facilitates the survival of splenic B cells via promoting autophagy and suppressing apoptosis
|
|
GO:0010508
positive regulation of autophagy
|
IMP
PMID:28747345 ORMDL3 Facilitates the Survival of Splenic B Cells via an AT... |
KEEP AS NON CORE |
Summary: Duplicate annotation for positive regulation of autophagy with IMP evidence from the same study. Ormdl3 knockout in mice showed reduced autophagy markers in splenic B cells.
Reason: Same rationale as the IDA annotation above. Autophagy regulation is a downstream pleiotropic effect of ORMDL3's primary sphingolipid regulatory function, not a core molecular activity.
Supporting Evidence:
PMID:28747345
ORMDL3 potentially mediates the autophagy via the ATF 6-Beclin1 autophagy pathway, and it facilitates the survival of splenic B cells via promoting autophagy and suppressing apoptosis
|
|
GO:1900182
positive regulation of protein localization to nucleus
|
IDA
PMID:28747345 ORMDL3 Facilitates the Survival of Splenic B Cells via an AT... |
KEEP AS NON CORE |
Summary: Dang et al. 2017 reported that ORMDL3 promotes nuclear localization of ATF6 (a UPR transcription factor). This likely reflects ORMDL3's effects on ER stress signaling through sphingolipid metabolism, not a direct protein transport function.
Reason: The positive regulation of protein localization to nucleus annotation appears to refer to ATF6 nuclear translocation as part of the UPR. This is an indirect downstream effect of ORMDL3's sphingolipid regulatory function, not a core activity.
Supporting Evidence:
PMID:28747345
we uncovered a role of ORMDL3 in fine-tuning B cell development and survival, besides highlighting a potential mechanism by which ORMDL3 regulates autophagy via ATF6 pathway
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6798743 |
REMOVE |
Summary: Reactome annotation placing ORMDL3 at the plasma membrane based on neutrophil degranulation pathway. ORMDL3 is an ER-resident protein with no experimental evidence for plasma membrane localization. The original discovery paper (PMID:12093374) explicitly showed no colocalization with plasma membrane markers.
Reason: ORMDL3 is established as an ER-resident multi-pass transmembrane protein. Hjelmqvist et al. 2002 showed that EGFP-ORMDL3 colocalizes with the ER marker PDI but showed no overlapping signal with plasma membrane marker concanavalin A. The Reactome pathway for neutrophil degranulation may include ORMDL3 based on proteomics of secretory granule fractions, but this does not represent the functional localization of ORMDL3.
Supporting Evidence:
PMID:12093374
double-label fluorescence with biotin-labeled concanavalin A... showed no overlapping signal with EGFP-ORMDL at the plasmatic membrane
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6799350 |
REMOVE |
Summary: Second Reactome annotation to plasma membrane from specific granule exocytosis pathway. Same issue as above.
Reason: No experimental evidence supports plasma membrane localization of ORMDL3. ORMDL3 is firmly established as an ER membrane protein by GFP-fusion, immunofluorescence, and cryo-EM structural studies.
|
|
GO:0030667
secretory granule membrane
|
TAS
Reactome:R-HSA-6798743 |
REMOVE |
Summary: Reactome annotation placing ORMDL3 in secretory granule membranes from the neutrophil degranulation pathway. While ORMDL3 may have been detected in proteomics of granule fractions, its established function and localization is in the ER as part of the SPT complex.
Reason: ORMDL3's confirmed localization and functional site is the ER membrane. Detection in granule proteomic fractions may reflect ER contamination or transit through the secretory pathway, not a functional localization.
|
|
GO:0035579
specific granule membrane
|
TAS
Reactome:R-HSA-6799350 |
REMOVE |
Summary: Reactome annotation to specific granule membrane from neutrophil-specific granule exocytosis pathway. Same concern as secretory granule membrane.
Reason: No functional evidence supports ORMDL3 localization to specific granule membranes. This likely arises from proteomic detection in granule fractions that may include ER membrane contaminants.
|
|
GO:0017059
serine palmitoyltransferase complex
|
IDA
PMID:25691431 ORMDL/serine palmitoyltransferase stoichiometry determines e... |
ACCEPT |
Summary: Siow et al. 2015 demonstrated that ORMDLs and SPT form stable complexes in human bronchial epithelial cells (HBECs) and HeLa cells, and that ORMDL is expressed in functional excess relative to SPT. Direct experimental evidence for SPT complex membership.
Reason: Core localization. Direct biochemical evidence for ORMDL3 as a component of the SPT complex in human cells.
Supporting Evidence:
PMID:25691431
ORMDLs and SPT form stable complexes that are not increased by elevated ORMDL3 expression
|
|
GO:1900060
negative regulation of ceramide biosynthetic process
|
IMP
PMID:25691431 ORMDL/serine palmitoyltransferase stoichiometry determines e... |
ACCEPT |
Summary: Siow et al. 2015 showed that ORMDL3 negatively regulates ceramide biosynthesis, though the relationship is complex due to ORMDL stoichiometry with SPT. At normal expression levels, ORMDL is in functional excess over SPT, meaning additional ORMDL3 does not further suppress biosynthesis.
Reason: Core function. ORMDL3's role as a negative regulator of ceramide biosynthesis (via SPT inhibition) is well established. This is the most specific biological process term available for ORMDL3's primary function.
Supporting Evidence:
PMID:25691431
The ORM1 (Saccharomyces cerevisiae)-like proteins (ORMDLs) and their yeast orthologs, the Orms, are negative homeostatic regulators of the initiating enzyme in sphingolipid biosynthesis, serine palmitoyltransferase (SPT)
|
|
GO:0005783
endoplasmic reticulum
|
IDA
PMID:12093374 ORMDL proteins are a conserved new family of endoplasmic ret... |
ACCEPT |
Summary: Original characterization of the ORMDL gene family by Hjelmqvist et al. 2002. GFP-ORMDL3 fusion protein colocalized with the ER marker PDI in COS-7 cells by confocal microscopy, establishing ER localization.
Reason: Primary experimental evidence for ER localization of ORMDL3. This is the foundational study establishing the subcellular localization of the ORMDL protein family.
Supporting Evidence:
PMID:12093374
Confocal scanning microscopy using an antibody against protein-disulfide isomerase (PDI), an ER-marker protein, showed an overlapping signal in the endoplasmic reticulum... these data show that the ORMDL proteins locate at the ER membrane
|
|
GO:0006672
ceramide metabolic process
|
IMP
PMID:20182505 Orm family proteins mediate sphingolipid homeostasis. |
ACCEPT |
Summary: Breslow et al. 2010 demonstrated that simultaneous RNAi knockdown of ORMDL1/2/3 in HeLa cells causes approximately three-fold increase in ceramide levels. This landmark study established the role of ORM/ORMDL proteins in sphingolipid homeostasis.
Reason: Core function. Direct experimental evidence that ORMDL proteins regulate ceramide levels in human cells.
Supporting Evidence:
PMID:20182505
we found that simultaneous knock-down by RNAi of ORMDL1/2/3 in Hela cells causes an approximately three-fold increase in ceramide levels
|
|
GO:0017059
serine palmitoyltransferase complex
|
IDA
PMID:20182505 Orm family proteins mediate sphingolipid homeostasis. |
ACCEPT |
Summary: Breslow et al. 2010 showed that Flag-tagged ORMDL3 co-immunoprecipitates with SPTLC1 from HEK293T cells, demonstrating the conserved physical association between ORMDL3 and the SPT complex in human cells.
Reason: Core localization. Direct co-IP evidence for ORMDL3 as a component of the SPT complex in human cells, confirmed by subsequent cryo-EM structures.
Supporting Evidence:
PMID:20182505
Immunoprecipitations from HEK293T cells expressing 3×Flag-tagged Ormdl3 led to a prominent Sptlc1 band detected by Western blot (Fig
|
|
GO:0004857
enzyme inhibitor activity
|
IDA
PMID:33558761 Structural insights into the regulation of human serine palm... |
NEW |
Summary: ORMDL3 functions as a direct inhibitor of the SPT enzyme by physically occluding the substrate entry tunnel through its N-terminus. Cryo-EM structures at 2.6 Angstrom resolution show that ORMDL3 blocks the substrate-binding tunnel and competes with substrate binding. This is the primary molecular function of ORMDL3.
Reason: ORMDL3 has no MF annotation other than the uninformative protein binding. The structural and biochemical evidence clearly demonstrates that ORMDL3 functions as an enzyme inhibitor of SPT. This is the core molecular function of the protein.
Supporting Evidence:
PMID:33558761
ORMDL3 blocks the tunnel and competes with substrate binding through its amino terminus
PMID:20182505
we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production
|
|
GO:0097001
ceramide binding
|
IDA
PMID:37308477 Ceramide sensing by human SPT-ORMDL complex for establishing... |
NEW |
Summary: Xie et al. 2023 demonstrated that ceramide binds to the N-terminus of ORMDL3, stabilizing an inhibitory conformation. Key residue Asn13 is critical for ceramide binding; N13A mutation disrupts ceramide responsiveness. Cryo-EM structures resolved the ceramide-bound SPT-ORMDL3 complex.
Reason: Ceramide binding is a critical molecular function of ORMDL3 that enables the homeostatic feedback loop. This is structurally and mutagenetically validated and represents a genuine molecular function annotation.
Supporting Evidence:
PMID:37308477
purified human SPT-ORMDL complexes are inhibited by the central sphingolipid metabolite ceramide. We have solved the cryo-EM structure of the SPT-ORMDL3 complex in a ceramide-bound state. Structure-guided mutational analyses reveal the essential function of this ceramide binding site for the suppression of SPT activity.
|
|
GO:0090155
negative regulation of sphingolipid biosynthetic process
|
IMP
PMID:20182505 Orm family proteins mediate sphingolipid homeostasis. |
NEW |
Summary: Breslow et al. 2010 established that ORM/ORMDL proteins are negative regulators of sphingolipid biosynthesis. RNAi knockdown of all three ORMDL genes in HeLa cells increased ceramide levels three-fold, demonstrating the negative regulatory role. This term captures the specific directionality of ORMDL3's regulatory function better than the more general terms currently annotated.
Reason: This term specifically captures ORMDL3's role as a negative regulator of sphingolipid biosynthesis, which is more precise than the existing GO:0030148 (sphingolipid biosynthetic process) annotation. The current GO annotations lack a biological process term that specifies the negative regulatory direction.
Supporting Evidence:
PMID:20182505
we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Comprehensive research report: Human ORMDL3 (UniProt Q8N138)
Verification of target identity and nomenclature
- Gene/protein match: ORMDL3 (ORMDL sphingolipid biosynthesis regulator 3) corresponds to a 153–amino-acid endoplasmic reticulum (ER)–anchored, multi-pass transmembrane protein encoded at chromosome 17q21, consistently described in recent reviews and disease-focused analyses, aligning with the UniProt-provided identity and nomenclature (human; ORM family) (zhang2023fromgeneidentifications pages 3-4, zhang2023fromgeneidentifications pages 1-2, malicevic2024modulationoforosomucoidlike pages 3-4). Zhang 2023 explicitly notes “human ORMDL3… 153 amino acids… ER-anchored transmembrane protein,” and places it in the 17q21 asthma risk locus with GSDMB and ZPBP2 (Chinese Medical Journal Pulmonary and Critical Care Medicine; online 14 Sep 2023; https://doi.org/10.1016/j.pccm.2023.08.001) (zhang2023fromgeneidentifications pages 3-4, zhang2023fromgeneidentifications pages 1-2). Malicevic 2024 similarly describes ORMDL3 as an ER-resident multi-pass protein of the ORMDL family at 17q21 (Journal of Biotechnology and Biomedicine; Oct 2024; https://doi.org/10.26502/jbb.2642-91280167) (malicevic2024modulationoforosomucoidlike pages 3-4). Demkova 2024 places ORMDL3 within the conserved ORM/ORMDL family (yeast ORM1/2; mammalian ORMDL1–3) (Frontiers in Immunology; 25 Apr 2024; https://doi.org/10.3389/fimmu.2024.1376629) (demkova2024simultaneousdeletionof pages 14-14).
Key concepts and definitions with current understanding
- Primary role: ER-resident regulator of de novo sphingolipid biosynthesis via direct inhibition of serine palmitoyltransferase (SPT), the first and rate-limiting step in sphingolipid production; ORMDL3 is a regulatory subunit of the SPT complex (demkova2024simultaneousdeletionof pages 14-14, mahawar2025intricateregulationof pages 4-6). Recent structural and mechanistic syntheses emphasize that ORMDL3 regulates SPT through direct physical association and ceramide-dependent feedback (BioEssays; 3 Jun 2025; https://doi.org/10.1002/bies.70036) (mahawar2025intricateregulationof pages 4-6).
- Feedback mechanism: Ceramide binds to the human SPT–ORMDL complex to signal elevated sphingolipid levels; this promotes ORMDL-mediated SPT inhibition, forming a homeostatic negative-feedback loop (demkova2024simultaneousdeletionof pages 14-14, mahawar2025intricateregulationof pages 4-6). Mutations in conserved sites (e.g., ORMDL3 Asn13) reduce ceramide responsiveness, supporting the model (mahawar2025intricateregulationof pages 4-6).
- Additional cellular roles: ORMDL3 perturbs ER Ca2+ homeostasis (reported interaction with SERCA), activates components of the unfolded protein response (UPR; especially ATF6, PERK–eIF2α), and intersects with autophagy and inflammasome signaling (malicevic2024modulationoforosomucoidlike pages 4-6, malicevic2024modulationoforosomucoidlike pages 3-4). In airway and immune cells, ORMDL3 influences ICAM1 expression, eosinophil activation/trafficking, and airway smooth muscle proliferation and Ca2+ oscillations (zhang2023fromgeneidentifications pages 3-4).
- Localization/topology: Conserved ER membrane protein, multi-pass transmembrane, acting in cis at the ER where SPT resides (zhang2023fromgeneidentifications pages 3-4, demkova2024simultaneousdeletionof pages 14-14, malicevic2024modulationoforosomucoidlike pages 3-4).
Recent developments and latest research (2023–2024 priority; 2025 select)
- Mechanistic regulation of SPT and ceramide feedback: Contemporary structural/mechanistic review consolidates that ORMDL3 is embedded in the SPT complex, with the ORMDL N-terminus occluding the SPT substrate site and ceramide binding modulating inhibition sensitivity—detailing a multilayered control of sphingolipid biosynthesis (BioEssays 2025; https://doi.org/10.1002/bies.70036) (mahawar2025intricateregulationof pages 4-6).
- Immune homeostasis and lymphocyte development: In mice, simultaneous deletion of Ormdl1 and Ormdl3 disrupts blood and splenic immune cell homeostasis, with elevated sphingolipid production in bone marrow and spleen; B-cell developmental defects were intrinsic (competitive bone marrow transplantation) (Frontiers in Immunology 2024; https://doi.org/10.3389/fimmu.2024.1376629) (demkova2024simultaneousdeletionof pages 14-14).
- Inflammatory bowel disease (IBD) perspective: Network and literature synthesis highlights ORMDL3 as a central hub linking ER stress/UPR, autophagy, inflammasome signaling (NLRP3), oxidative stress, and mitochondrial dysfunction; the review argues ORMDL3 is a rational therapeutic target in IBD (Journal of Biotechnology and Biomedicine 2024; https://doi.org/10.26502/jbb.2642-91280167) (malicevic2024modulationoforosomucoidlike pages 10-12, malicevic2024modulationoforosomucoidlike pages 4-6, malicevic2024modulationoforosomucoidlike pages 3-4).
- Innate immune signaling and oncology: ORMDL3 negatively regulates type I IFN signaling by binding MAVS and promoting proteasome-mediated RIG-I degradation through disrupting USP10–RIG-I interaction; ORMDL3 inhibition enhanced anti-tumor CD8+ T cell responses in syngeneic mouse models (eLife; Version of Record 24 Mar 2025; https://doi.org/10.7554/elife.101973.3) (zeng2025ormdl3restrainstype pages 1-2).
- Asthma genetics and translational framing: 2023 review positions ORMDL3 among top GWAS-implicated asthma genes with therapeutic potential, summarizing functional roles across airway structural and immune cells (Chinese Medical Journal Pulmonary and Critical Care Medicine 2023; https://doi.org/10.1016/j.pccm.2023.08.001) (zhang2023fromgeneidentifications pages 3-4, zhang2023fromgeneidentifications pages 1-2).
Current applications and real-world implementations
- Pharmacogenomics of inhaled corticosteroid (ICS) response: A pediatric biobank study reported that combined rare+common variants at the GSDMB/ORMDL3 locus were associated with ICS response (defined as ED visits/hospitalizations over one year) in White children in the discovery cohort (PrecisionLink Biobank: N=91 White; p=0.003) and replicated in the BIG Initiative (N=83 White; p=0.02) using region-based SKAT tests adjusted for age, sex, BMI with Bonferroni correction (0.05/12=0.004) (Genes; published 28 Mar 2024; https://doi.org/10.3390/genes15040420) (voorhies2024gsdmbormdl3rarecommonvariants pages 1-2, voorhies2024gsdmbormdl3rarecommonvariants pages 2-4). Secondary single-variant analyses (PrecisionLink White) identified nominal associations for intronic SNPs such as rs4065275 (beta 1.33, SE 0.53, p=0.01), rs2290400 (beta 1.07, SE 0.48, p=0.02), rs36000226 (beta 0.93, SE 0.42, p=0.03), among others; the joint signal appeared polygenic across multiple intronic SNPs (voorhies2024gsdmbormdl3rarecommonvariants pages 4-5, voorhies2024gsdmbormdl3rarecommonvariants pages 5-7). Limitations include small sample sizes (especially Black children in PrecisionLink, N=20) and EHR-derived outcomes (voorhies2024gsdmbormdl3rarecommonvariants pages 5-7).
- Clinical correlates of expression (asthma control, FeNO): In 97 children (59 asthmatic; 38 controls), ORMDL3 expression was 6.74-fold higher in poorly controlled asthma (ACT ≤15) versus well controlled (ACT ≥20) with significant difference for ΔCq (p=0.015), and ΔCq correlated negatively with ACT (p=0.003, r=-0.418); FeNO >25 ppb associated with a 2.93-fold higher ORMDL3 expression (p≈0.051) (Northern Clinics of Istanbul; online 28 Nov 2023; https://doi.org/10.14744/nci.2023.22120) (almacıoglu2023associationofchildhood pages 4-6, almacıoglu2023associationofchildhood pages 1-2). GSDMB expression tracked similarly (11.74-fold higher at low ACT; ΔCq correlation p=0.016, r=-0.345) and strongly correlated with ORMDL3 expression (r=0.80, p<0.001) (almacıoglu2023associationofchildhood pages 1-2).
Expert opinions and authoritative analyses
- Mechanistic expert synthesis: BioEssays 2025 provides an authoritative, mechanism-centric review consolidating cryo-EM and mutational evidence for ORMDL3-regulated SPT inhibition and ceramide feedback, placing ORMDL3 as an integral regulatory subunit of the SPT complex that enforces homeostasis of sphingolipid biosynthesis (https://doi.org/10.1002/bies.70036) (mahawar2025intricateregulationof pages 4-6).
- Disease-focused expert framing: Zhang 2023 argues ORMDL3 is a high-potential asthma therapeutic target based on replicated 17q21 genetics and multi-system functional evidence across airway epithelium and immune compartments (https://doi.org/10.1016/j.pccm.2023.08.001) (zhang2023fromgeneidentifications pages 3-4, zhang2023fromgeneidentifications pages 1-2). Malicevic 2024 designates ORMDL3 as a hub gene linking ER stress/UPR and inflammatory/autophagy pathways, supporting therapeutic exploration in IBD (https://doi.org/10.26502/jbb.2642-91280167) (malicevic2024modulationoforosomucoidlike pages 10-12, malicevic2024modulationoforosomucoidlike pages 4-6, malicevic2024modulationoforosomucoidlike pages 3-4).
Relevant statistics and data from recent studies
- Pediatric ICS response pharmacogenomics: GSDMB/ORMDL3 region-based association in White children—PrecisionLink discovery N=91 White (p=0.003) with replication in BIG N=83 White (p=0.02). Single-SNP examples: rs4065275 beta 1.33 (SE 0.53; p=0.01); rs2290400 beta 1.07 (SE 0.48; p=0.02); rs36000226 beta 0.93 (SE 0.42; p=0.03) (Genes; 28 Mar 2024; https://doi.org/10.3390/genes15040420) (voorhies2024gsdmbormdl3rarecommonvariants pages 4-5, voorhies2024gsdmbormdl3rarecommonvariants pages 1-2).
- Pediatric asthma control and biomarkers: In 59 asthmatic children vs 38 controls, ORMDL3 expression increased 6.74-fold at ACT ≤15 vs ≥20 (p=0.015); ΔCq–ACT correlation r=-0.418 (p=0.003). FeNO >25 ppb had ~2.93-fold higher ORMDL3 (p≈0.051). FeNO correlated negatively with ACT (r=-0.56, p<0.0001) (Northern Clinics of Istanbul; 28 Nov 2023; https://doi.org/10.14744/nci.2023.22120) (almacıoglu2023associationofchildhood pages 4-6, almacıoglu2023associationofchildhood pages 1-2).
- Mouse immunology and lipids: Ormdl1/Ormdl3 double deletion reduced immune cell content in blood/spleen, with strongly increased sphingolipid production in spleen and bone marrow; B-cell defects were cell intrinsic (Frontiers in Immunology; 25 Apr 2024; https://doi.org/10.3389/fimmu.2024.1376629) (demkova2024simultaneousdeletionof pages 14-14).
Functional mechanism and pathway placement
- Biochemical function: ORMDL3 is a non-enzymatic transmembrane regulator that inhibits SPT within the ER, implementing ceramide-responsive negative feedback to maintain sphingolipid homeostasis (demkova2024simultaneousdeletionof pages 14-14, mahawar2025intricateregulationof pages 4-6). This places ORMDL3 at the very entry point of de novo sphingolipid synthesis, upstream of ceramide and sphingosine-1-phosphate pools that influence cell signaling and membrane composition (zhang2023fromgeneidentifications pages 3-4, mahawar2025intricateregulationof pages 4-6).
- Cellular compartment: ER membrane; multi-pass topology consistent with direct association to ER-localized SPT and modulation of ER Ca2+ handling and UPR (zhang2023fromgeneidentifications pages 3-4, demkova2024simultaneousdeletionof pages 14-14, malicevic2024modulationoforosomucoidlike pages 3-4).
- Pathways: Sphingolipid metabolism (SPT–ORMDL3 complex; ceramide feedback), ER stress/UPR (ATF6, PERK–eIF2α; IRE1/NF-κB links), calcium homeostasis (SERCA interaction), autophagy (Beclin-1 regulation), inflammasome (NLRP3 via TXNIP and ER–mitochondria contacts), and innate antiviral signaling (RIG-I/MAVS axis) (mahawar2025intricateregulationof pages 4-6, malicevic2024modulationoforosomucoidlike pages 4-6, malicevic2024modulationoforosomucoidlike pages 3-4, zeng2025ormdl3restrainstype pages 1-2).
Caveats and open questions
- Pharmacogenomic signals at GSDMB/ORMDL3 for ICS response are promising but derive from modest sample sizes and EHR-defined outcomes; effect estimates are preliminary and race-stratified replication remains limited (voorhies2024gsdmbormdl3rarecommonvariants pages 1-2, voorhies2024gsdmbormdl3rarecommonvariants pages 5-7). Expression–phenotype associations in pediatric asthma suggest utility as biomarkers of poor control, but larger, longitudinal cohorts and standardized protocols are needed to validate thresholds and clinical integration (almacıoglu2023associationofchildhood pages 1-2).
Embedded summary of recent sources
| Year | Source (first author, journal) | Topic / Focus | Key mechanistic or clinical findings | Organism / Model | URL / DOI |
|------|--------------------------------|---------------|--------------------------------------|------------------|-----------|
| 2023 | Zhang Y., Chinese Medical Journal Pulmonary and Critical Care Medicine | Asthma genetics & therapeutic targets | ORMDL3 (153 aa) at 17q21; ER-anchored multi-pass protein that regulates SPT and sphingolipid levels, alters ER Ca2+ handling and airway cell/immune responses (zhang2023fromgeneidentifications pages 3-4) | Human / airway cells; review | https://doi.org/10.1016/j.pccm.2023.08.001 |
| 2024 | Demkova L., Frontiers in Immunology | Immune cell homeostasis; KO models | Simultaneous Ormdl1/Ormdl3 deletion disrupts immune cell homeostasis and increases sphingolipid production (spleen, bone marrow); B-cell development defects shown in competitive BM transplant assays (demkova2024simultaneousdeletionof pages 14-14) | Mouse double/single knockouts | https://doi.org/10.3389/fimmu.2024.1376629 |
| 2024 | Malicevic U., Journal of Biotechnology and Biomedicine | IBD, ER stress, autophagy, inflammasome | ORMDL3 links sphingolipid metabolism to ER stress/UPR (ATF6/IRE1/PERK), perturbs ER Ca2+ (SERCA inhibition), modulates autophagy and NLRP3 inflammasome; proposed therapeutic target in IBD (malicevic2024modulationoforosomucoidlike pages 10-12, malicevic2024modulationoforosomucoidlike pages 4-6) | Human tissues, cellular assays, network analyses | https://doi.org/10.26502/jbb.2642-91280167 |
| 2025 | Mahawar U., BioEssays | SPT–ORMDL structural and regulatory mechanisms | ORMDL3 functions as regulatory subunit of SPT; cryo-EM and mutagenesis indicate ORMDL N‑terminus occludes SPT substrate site and mediates ceramide-feedback (key residues e.g., Asn13); mechanistic basis for homeostatic SPT inhibition (mahawar2025intricateregulationof pages 4-6) | Structural/biochemical studies; review | https://doi.org/10.1002/bies.70036 |
| 2025 | Zeng Q., eLife | Innate immunity, RIG‑I signaling, tumor immunity | ORMDL3 interacts with MAVS and USP10 to promote RIG‑I proteasomal degradation, restraining type I IFN signaling; ORMDL3 inhibition enhances anti‑tumor CD8+ T cell responses in mouse models (zeng2025ormdl3restrainstype pages 1-2) | Mouse tumor models; IP‑MS and in vivo validation | https://doi.org/10.7554/elife.101973.3 |
Table: Concise 2023–2025 table of authoritative papers on human ORMDL3 summarizing function, localization, pathway mechanisms, disease relevance, and DOI links; citations reference the gathered evidence (zhang2023fromgeneidentifications pages 3-4, zeng2025ormdl3restrainstype pages 1-2).
Conclusion
Human ORMDL3 (Q8N138) is a conserved, multi-pass ER membrane regulator that gates SPT activity and enforces ceramide-dependent feedback across sphingolipid biosynthesis. Recent work consolidates its mechanistic role in SPT inhibition and extends ORMDL3’s functional reach to ER calcium/UPR–autophagy–inflammasome networks and to innate immunity via RIG-I turnover. Translationally, ORMDL3 remains a priority target candidate in asthma (17q21) with early pharmacogenomic signals for pediatric ICS response, and is emerging as a hub candidate in IBD. Future directions include structure-guided modulation of the SPT–ORMDL interface, selective interference with ceramide sensing, and evaluation of ORMDL3-targeted approaches to fine-tune sphingolipid flux and immune signaling in airway and intestinal disease (zhang2023fromgeneidentifications pages 3-4, demkova2024simultaneousdeletionof pages 14-14, mahawar2025intricateregulationof pages 4-6, malicevic2024modulationoforosomucoidlike pages 10-12, malicevic2024modulationoforosomucoidlike pages 4-6, zhang2023fromgeneidentifications pages 1-2, malicevic2024modulationoforosomucoidlike pages 3-4, zeng2025ormdl3restrainstype pages 1-2, almacıoglu2023associationofchildhood pages 4-6, voorhies2024gsdmbormdl3rarecommonvariants pages 2-4, voorhies2024gsdmbormdl3rarecommonvariants pages 4-5, almacıoglu2023associationofchildhood pages 1-2, voorhies2024gsdmbormdl3rarecommonvariants pages 1-2, voorhies2024gsdmbormdl3rarecommonvariants pages 5-7, almacıoglu2023associationofchildhood pages 7-9).
References
(zhang2023fromgeneidentifications pages 3-4): Youming Zhang. From gene identifications to therapeutic targets for asthma: focus on great potentials of tslp, ormdl3, and gsdmb. Chinese Medical Journal Pulmonary and Critical Care Medicine, 1:139-147, Sep 2023. URL: https://doi.org/10.1016/j.pccm.2023.08.001, doi:10.1016/j.pccm.2023.08.001. This article has 10 citations.
(zhang2023fromgeneidentifications pages 1-2): Youming Zhang. From gene identifications to therapeutic targets for asthma: focus on great potentials of tslp, ormdl3, and gsdmb. Chinese Medical Journal Pulmonary and Critical Care Medicine, 1:139-147, Sep 2023. URL: https://doi.org/10.1016/j.pccm.2023.08.001, doi:10.1016/j.pccm.2023.08.001. This article has 10 citations.
(malicevic2024modulationoforosomucoidlike pages 3-4): Ugljesa Malicevic, Vikrant Rai, Ranko Skrbic, and Devendra K Agrawal. Modulation of orosomucoid-like protein 3 activity in the management of inflammatory bowel disease. Journal of biotechnology and biomedicine, 7:433-444, Oct 2024. URL: https://doi.org/10.26502/jbb.2642-91280167, doi:10.26502/jbb.2642-91280167. This article has 6 citations.
(demkova2024simultaneousdeletionof pages 14-14): Livia Demkova, Viktor Bugajev, Miroslava K. Adamcova, Ladislav Kuchar, Srdjan Grusanovic, Meritxell Alberich-Jorda, Petr Draber, and Ivana Halova. Simultaneous deletion of ormdl1 and ormdl3 proteins disrupts immune cell homeostasis. Frontiers in Immunology, Apr 2024. URL: https://doi.org/10.3389/fimmu.2024.1376629, doi:10.3389/fimmu.2024.1376629. This article has 3 citations and is from a peer-reviewed journal.
(mahawar2025intricateregulationof pages 4-6): Usha Mahawar and Binks Wattenberg. Intricate regulation of sphingolipid biosynthesis: an in-depth look into ormdl-mediated regulation of serine palmitoyltransferase. BioEssays : news and reviews in molecular, cellular and developmental biology, pages e70036, Jun 2025. URL: https://doi.org/10.1002/bies.70036, doi:10.1002/bies.70036. This article has 2 citations.
(malicevic2024modulationoforosomucoidlike pages 4-6): Ugljesa Malicevic, Vikrant Rai, Ranko Skrbic, and Devendra K Agrawal. Modulation of orosomucoid-like protein 3 activity in the management of inflammatory bowel disease. Journal of biotechnology and biomedicine, 7:433-444, Oct 2024. URL: https://doi.org/10.26502/jbb.2642-91280167, doi:10.26502/jbb.2642-91280167. This article has 6 citations.
(malicevic2024modulationoforosomucoidlike pages 10-12): Ugljesa Malicevic, Vikrant Rai, Ranko Skrbic, and Devendra K Agrawal. Modulation of orosomucoid-like protein 3 activity in the management of inflammatory bowel disease. Journal of biotechnology and biomedicine, 7:433-444, Oct 2024. URL: https://doi.org/10.26502/jbb.2642-91280167, doi:10.26502/jbb.2642-91280167. This article has 6 citations.
(zeng2025ormdl3restrainstype pages 1-2): Qi Zeng, Chen Yao, Shi-Qiang Zhang, Yizhi Mao, Jing Wang, Ziyang Wang, Chunjie Sheng, and Shuai Chen. Ormdl3 restrains type i interferon signaling and anti-tumor immunity by promoting rig-i degradation. eLife, Mar 2025. URL: https://doi.org/10.7554/elife.101973.3, doi:10.7554/elife.101973.3. This article has 2 citations and is from a domain leading peer-reviewed journal.
(voorhies2024gsdmbormdl3rarecommonvariants pages 1-2): Kirsten Voorhies, Akram Mohammed, Lokesh Chinthala, Sek Won Kong, In-Hee Lee, Alvin T. Kho, Michael McGeachie, Kenneth D. Mandl, Benjamin Raby, Melanie Hayes, Robert L. Davis, Ann Chen Wu, and Sharon M. Lutz. Gsdmb/ormdl3 rare/common variants are associated with inhaled corticosteroid response among children with asthma. Genes, 15:420, Mar 2024. URL: https://doi.org/10.3390/genes15040420, doi:10.3390/genes15040420. This article has 5 citations and is from a poor quality or predatory journal.
(voorhies2024gsdmbormdl3rarecommonvariants pages 2-4): Kirsten Voorhies, Akram Mohammed, Lokesh Chinthala, Sek Won Kong, In-Hee Lee, Alvin T. Kho, Michael McGeachie, Kenneth D. Mandl, Benjamin Raby, Melanie Hayes, Robert L. Davis, Ann Chen Wu, and Sharon M. Lutz. Gsdmb/ormdl3 rare/common variants are associated with inhaled corticosteroid response among children with asthma. Genes, 15:420, Mar 2024. URL: https://doi.org/10.3390/genes15040420, doi:10.3390/genes15040420. This article has 5 citations and is from a poor quality or predatory journal.
(voorhies2024gsdmbormdl3rarecommonvariants pages 4-5): Kirsten Voorhies, Akram Mohammed, Lokesh Chinthala, Sek Won Kong, In-Hee Lee, Alvin T. Kho, Michael McGeachie, Kenneth D. Mandl, Benjamin Raby, Melanie Hayes, Robert L. Davis, Ann Chen Wu, and Sharon M. Lutz. Gsdmb/ormdl3 rare/common variants are associated with inhaled corticosteroid response among children with asthma. Genes, 15:420, Mar 2024. URL: https://doi.org/10.3390/genes15040420, doi:10.3390/genes15040420. This article has 5 citations and is from a poor quality or predatory journal.
(voorhies2024gsdmbormdl3rarecommonvariants pages 5-7): Kirsten Voorhies, Akram Mohammed, Lokesh Chinthala, Sek Won Kong, In-Hee Lee, Alvin T. Kho, Michael McGeachie, Kenneth D. Mandl, Benjamin Raby, Melanie Hayes, Robert L. Davis, Ann Chen Wu, and Sharon M. Lutz. Gsdmb/ormdl3 rare/common variants are associated with inhaled corticosteroid response among children with asthma. Genes, 15:420, Mar 2024. URL: https://doi.org/10.3390/genes15040420, doi:10.3390/genes15040420. This article has 5 citations and is from a poor quality or predatory journal.
(almacıoglu2023associationofchildhood pages 4-6): M. Almacıoğlu, Ozlem Keskin, M. Ozkars, Sibel Oguzkan Balci, E. Kucukosmanoglu, S. Pehlivan, and Mehmet Keskin. Association of childhood asthma with gasdermin b (gsdmb) and oromucoid-like 3 (ormdl3) genes. Northern Clinics of Istanbul, 10:769-777, Nov 2023. URL: https://doi.org/10.14744/nci.2023.22120, doi:10.14744/nci.2023.22120. This article has 2 citations.
(almacıoglu2023associationofchildhood pages 1-2): M. Almacıoğlu, Ozlem Keskin, M. Ozkars, Sibel Oguzkan Balci, E. Kucukosmanoglu, S. Pehlivan, and Mehmet Keskin. Association of childhood asthma with gasdermin b (gsdmb) and oromucoid-like 3 (ormdl3) genes. Northern Clinics of Istanbul, 10:769-777, Nov 2023. URL: https://doi.org/10.14744/nci.2023.22120, doi:10.14744/nci.2023.22120. This article has 2 citations.
(almacıoglu2023associationofchildhood pages 7-9): M. Almacıoğlu, Ozlem Keskin, M. Ozkars, Sibel Oguzkan Balci, E. Kucukosmanoglu, S. Pehlivan, and Mehmet Keskin. Association of childhood asthma with gasdermin b (gsdmb) and oromucoid-like 3 (ormdl3) genes. Northern Clinics of Istanbul, 10:769-777, Nov 2023. URL: https://doi.org/10.14744/nci.2023.22120, doi:10.14744/nci.2023.22120. This article has 2 citations.
id: Q8N138
gene_symbol: ORMDL3
product_type: PROTEIN
status: IN_PROGRESS
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
ORMDL3 (ORM1-like protein 3) is a conserved, multi-pass transmembrane protein
of 153 amino acids that resides in the endoplasmic reticulum (ER) membrane. It
functions as a ceramide-sensitive regulatory subunit of the serine
palmitoyltransferase (SPT) complex (SPTLC1/SPTLC2/ssSPTa/ORMDL3), the enzyme
that catalyzes the first and rate-limiting step in de novo sphingolipid
biosynthesis. ORMDL3 acts as a negative regulator of SPT: its N-terminus
physically occludes the substrate entry tunnel of SPT, and this inhibitory
conformation is stabilized by ceramide binding, thereby implementing a
homeostatic negative feedback loop that maintains sphingolipid levels.
Structurally resolved by cryo-EM, ORMDL3 has four transmembrane helices and a
cytoplasmic N-terminal ceramide-sensing region. The 17q21 locus containing
ORMDL3 is the strongest and most replicated genetic risk locus for childhood
asthma. Beyond sphingolipid regulation, ORMDL3 has been implicated in ER
stress/UPR signaling, ER calcium homeostasis, and autophagy regulation in
immune cells, though these may represent downstream consequences of altered
sphingolipid metabolism rather than independent molecular functions.
alternative_products:
- name: '1'
id: Q8N138-1
- name: '2'
id: Q8N138-4
sequence_note: VSP_016052
existing_annotations:
# --- IBA annotations (phylogenetic inference) ---
- term:
id: GO:0030148
label: sphingolipid biosynthetic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
ORMDL3 is a regulatory subunit of the SPT complex that controls the
rate-limiting step in sphingolipid de novo biosynthesis. The IBA annotation
to sphingolipid biosynthetic process is well supported by the conserved
role of ORM/ORMDL family proteins in sphingolipid metabolism from yeast to
human (PMID:20182505, PMID:33558761).
action: ACCEPT
reason: >-
Core function. ORMDL3 is an integral component of the SPT complex and
directly regulates sphingolipid biosynthetic flux. This is phylogenetically
conserved across the ORM family.
supported_by:
- reference_id: PMID:20182505
supporting_text: >-
Orm family proteins mediate sphingolipid homeostasis... we identify Orm
proteins as negative regulators of sphingolipid synthesis that form a
conserved complex with serine palmitoyltransferase, the first and
rate-limiting enzyme in sphingolipid production.
- reference_id: PMID:33558761
supporting_text: >-
the first and rate-limiting step of sphingolipid synthesis is catalyzed
by the serine palmitoyltransferase holocomplex, which consists of
catalytic components (SPTLC1 and SPTLC2) and regulatory components
(ssSPTa and ORMDL3).
additional_reference_ids:
- file:human/ORMDL3/ORMDL3-deep-research-falcon.md
- term:
id: GO:0090156
label: intracellular sphingolipid homeostasis
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
ORMDL3 implements ceramide-dependent negative feedback on SPT to maintain
sphingolipid homeostasis. Ceramide binding to the ORMDL3 N-terminus
stabilizes an inhibitory conformation that blocks SPT substrate entry,
constituting a homeostatic sensor mechanism (PMID:20182505,
PMID:37308477).
action: ACCEPT
reason: >-
Core function. ORMDL3 is the ceramide-sensing subunit of the SPT complex
that provides homeostatic feedback regulation of sphingolipid levels. This
is the primary evolved role of the ORM/ORMDL family.
supported_by:
- reference_id: PMID:20182505
supporting_text: >-
Orm proteins are dynamic negative regulators of serine
palmitoyltransferase whose inhibitory activity is dependent on adequate
levels of downstream sphingolipids
- reference_id: PMID:37308477
supporting_text: >-
Structural studies indicate that ceramide can induce and lock the
N-terminus of ORMDL3 into an inhibitory conformation.
- term:
id: GO:0017059
label: serine palmitoyltransferase complex
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
ORMDL3 is a stoichiometric subunit of the SPT complex. The phylogenetic
inference is consistent with conserved physical association of ORM/ORMDL
proteins with SPT from yeast to human, confirmed by co-IP and cryo-EM
structural studies (PMID:20182505, PMID:33558761, PMID:33558762).
action: ACCEPT
reason: >-
Core localization. Structural and biochemical data confirm ORMDL3 is an
integral subunit of the SPT holoenzyme complex.
supported_by:
- reference_id: PMID:20182505
supporting_text: >-
Immunoprecipitations from HEK293T cells expressing 3×Flag-tagged Ormdl3
led to a prominent Sptlc1 band detected by Western blot (Fig
- term:
id: GO:0006672
label: ceramide metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
ORMDL3 regulates ceramide levels by controlling SPT activity, the
rate-limiting step upstream of ceramide synthesis. This IBA annotation is
phylogenetically sound, as yeast ORM proteins also regulate ceramide
levels (PMID:20182505).
action: ACCEPT
reason: >-
Ceramide levels are directly controlled by ORMDL3-mediated regulation of
SPT. Loss of ORM/ORMDL function leads to elevated ceramide levels in both
yeast and human cells.
supported_by:
- reference_id: PMID:20182505
supporting_text: >-
we found that simultaneous knock-down by RNAi of ORMDL1/2/3 in Hela
cells causes an approximately three-fold increase in ceramide levels
# --- IEA annotations (electronic inference) ---
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
ORMDL3 is an ER membrane-resident multi-pass transmembrane protein. This
IEA is consistent with experimental data showing ER membrane localization
by GFP-tagging (PMID:12093374), immunofluorescence (PMID:19819884), and
cryo-EM structures showing ORMDL3 embedded in the membrane within the SPT
complex (PMID:33558761, PMID:33558762).
action: ACCEPT
reason: >-
Correct and well-supported. UniProt annotation from subcellular
localization data; multiple experimental lines confirm ER membrane
localization.
supported_by:
- reference_id: PMID:12093374
supporting_text: >-
fusion proteins of enhanced green fluorescent protein and ORMDL
(EGFP-ORMDL) appeared predominantly in the perinuclear endoplasmic
reticulum (ER) and, to a lesser extent, throughout the extended ER
network
- term:
id: GO:0006665
label: sphingolipid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
IEA annotation to sphingolipid metabolic process from ARBA. This is
correct but broader than the more specific IBA annotations already present
(GO:0030148 sphingolipid biosynthetic process, GO:0090156 intracellular
sphingolipid homeostasis).
action: ACCEPT
reason: >-
Correct parent term. Although more specific terms are already annotated
via IBA, this broader IEA annotation is not wrong and reflects the general
role of ORMDL3 in sphingolipid metabolism.
- term:
id: GO:0016020
label: membrane
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
Generic membrane annotation from InterPro domain mapping. ORMDL3 is
indeed a multi-pass transmembrane protein with four transmembrane helices.
action: ACCEPT
reason: >-
Correct but very generic. More specific ER membrane annotation is also
present. This is an acceptable broad IEA.
- term:
id: GO:2000303
label: regulation of ceramide biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
IEA from ARBA for regulation of ceramide biosynthetic process. This is
correct but could be more specific: ORMDL3 is a negative regulator, and
the more specific child term GO:1900060 (negative regulation of ceramide
biosynthetic process) is already annotated via IMP.
action: ACCEPT
reason: >-
Correct at the level of specificity typical for IEA. The more precise
negative regulation term (GO:1900060) is captured by the IMP annotation
from PMID:25691431.
# --- Protein binding annotations (IPI) ---
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20182505
review:
summary: >-
Physical interaction between ORMDL3 and SPTLC1 (O15269) demonstrated by
co-immunoprecipitation from HEK293T cells expressing 3xFlag-tagged
ORMDL3 (PMID:20182505). This interaction is functionally significant as
ORMDL3 is a regulatory subunit of the SPT complex.
action: MODIFY
reason: >-
The protein binding annotation is uninformative. The interaction with
SPTLC1 reflects ORMDL3's role as a subunit of the SPT complex. A more
informative annotation would be enzyme inhibitor activity (GO:0004857),
reflecting ORMDL3's function as a direct inhibitor of SPT catalytic
activity through physical interaction.
proposed_replacement_terms:
- id: GO:0004857
label: enzyme inhibitor activity
supported_by:
- reference_id: PMID:20182505
supporting_text: >-
Immunoprecipitations from HEK293T cells expressing 3×Flag-tagged Ormdl3
led to a prominent Sptlc1 band detected by Western blot (Fig
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
review:
summary: >-
High-throughput binary protein interactome study (HuRI) reporting many
interactions for ORMDL3. Most of these interactions (with AQP6, ARL13B,
various GPCRs, channels, etc.) lack functional validation and likely
represent the promiscuous detection typical of membrane protein screens.
The biologically meaningful interactions are with SPT complex components,
not with the diverse set of membrane proteins identified here.
action: MARK_AS_OVER_ANNOTATED
reason: >-
High-throughput interactome data. The 25+ distinct interactors from this
single study include many membrane proteins with no known functional
relationship to ORMDL3 (e.g., AQP6, GPR101, GPR152, ROM1). Generic
protein binding from HT screens is uninformative for ORMDL3's function.
supported_by:
- reference_id: PMID:32296183
supporting_text: >-
Here we present a human 'all-by-all' reference interactome map of human
binary protein interactions, or 'HuRI'. With approximately 53,000
protein-protein interactions
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33558761
review:
summary: >-
Cryo-EM structure of the human SPT-ORMDL3 complex at 2.6 Angstrom
resolution demonstrates direct physical contact between ORMDL3 and SPTLC1
(O15269) within the SPT holoenzyme (PMID:33558761). This is structurally
validated interaction, not mere binding.
action: MODIFY
reason: >-
The protein binding term is uninformative. The structural data reveal
that ORMDL3 physically occludes the SPT substrate entry tunnel, acting as
an enzyme inhibitor. This should be annotated as enzyme inhibitor activity.
proposed_replacement_terms:
- id: GO:0004857
label: enzyme inhibitor activity
supported_by:
- reference_id: PMID:33558761
supporting_text: >-
ORMDL3 blocks the tunnel and competes with substrate binding through
its amino terminus
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33558762
review:
summary: >-
Second independent cryo-EM structure study of the SPT-ORMDL3 complex
(Li et al. 2021) confirming physical interaction between ORMDL3 and
SPTLC1 within the SPT holoenzyme at 3.2 Angstrom resolution.
action: MODIFY
reason: >-
As with PMID:33558761, the generic protein binding annotation is
uninformative. The structural interaction represents enzyme inhibitor
activity within the SPT complex.
proposed_replacement_terms:
- id: GO:0004857
label: enzyme inhibitor activity
supported_by:
- reference_id: PMID:33558762
supporting_text: >-
ORMDL3 is located in the center of the complex, serving to stabilize
the SPT assembly
# --- IDA annotations ---
- term:
id: GO:0005783
label: endoplasmic reticulum
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: >-
IDA annotation from HPA immunofluorescence data. ORMDL3 localizes to the
ER, consistent with its known ER membrane topology and function as an SPT
complex subunit.
action: ACCEPT
reason: >-
Correct. ER localization is the primary subcellular localization of
ORMDL3, confirmed by multiple methods including GFP-fusion (PMID:12093374),
immunofluorescence (PMID:19819884), and cryo-EM structures.
# --- Annotations from PMID:28747345 (Dang et al. 2017, B cell autophagy) ---
- term:
id: GO:0002903
label: negative regulation of B cell apoptotic process
evidence_type: IMP
original_reference_id: PMID:28747345
review:
summary: >-
Dang et al. 2017 showed that Ormdl3 knockout mice have increased
apoptosis of splenic B cells, and that ORMDL3 facilitates B cell survival
via ATF6-Beclin1 autophagy pathway. The annotation reflects a downstream
phenotypic consequence in the immune system.
action: KEEP_AS_NON_CORE
reason: >-
This is a pleiotropic downstream effect likely mediated through ORMDL3's
primary role in sphingolipid/ER stress regulation, rather than a direct
molecular function of ORMDL3 in anti-apoptotic signaling. B cell survival
effects are likely secondary to altered sphingolipid metabolism and ER
stress responses.
supported_by:
- reference_id: PMID:28747345
supporting_text: >-
silencing Ormdl3 in vivo significantly decreased the proportions of
mature B lymphocytes and transitional 2B cells in spleen... knockdown
of Ormdl3 augmented the apoptosis of total splenic cells and splenic
CD19+ B cells
- term:
id: GO:0010508
label: positive regulation of autophagy
evidence_type: IDA
original_reference_id: PMID:28747345
review:
summary: >-
Dang et al. 2017 showed ORMDL3 promotes autophagy via the ATF6-Beclin1
pathway. ORMDL3 overexpression increased Beclin1 and LC3-II expression
and increased autophagy marker levels. This likely reflects secondary
effects of ORMDL3's role in ER stress modulation.
action: KEEP_AS_NON_CORE
reason: >-
Autophagy regulation by ORMDL3 appears to be an indirect consequence of
its effects on ER stress/UPR signaling (ATF6 activation), which itself
may stem from altered sphingolipid metabolism. This is not a core
molecular function.
supported_by:
- reference_id: PMID:28747345
supporting_text: >-
ORMDL3 potentially mediates the autophagy via the ATF 6-Beclin1
autophagy pathway, and it facilitates the survival of splenic B cells
via promoting autophagy and suppressing apoptosis
- term:
id: GO:0010508
label: positive regulation of autophagy
evidence_type: IMP
original_reference_id: PMID:28747345
review:
summary: >-
Duplicate annotation for positive regulation of autophagy with IMP
evidence from the same study. Ormdl3 knockout in mice showed reduced
autophagy markers in splenic B cells.
action: KEEP_AS_NON_CORE
reason: >-
Same rationale as the IDA annotation above. Autophagy regulation is a
downstream pleiotropic effect of ORMDL3's primary sphingolipid regulatory
function, not a core molecular activity.
supported_by:
- reference_id: PMID:28747345
supporting_text: >-
ORMDL3 potentially mediates the autophagy via the ATF 6-Beclin1
autophagy pathway, and it facilitates the survival of splenic B cells
via promoting autophagy and suppressing apoptosis
- term:
id: GO:1900182
label: positive regulation of protein localization to nucleus
evidence_type: IDA
original_reference_id: PMID:28747345
review:
summary: >-
Dang et al. 2017 reported that ORMDL3 promotes nuclear localization of
ATF6 (a UPR transcription factor). This likely reflects ORMDL3's effects
on ER stress signaling through sphingolipid metabolism, not a direct
protein transport function.
action: KEEP_AS_NON_CORE
reason: >-
The positive regulation of protein localization to nucleus annotation
appears to refer to ATF6 nuclear translocation as part of the UPR. This
is an indirect downstream effect of ORMDL3's sphingolipid regulatory
function, not a core activity.
supported_by:
- reference_id: PMID:28747345
supporting_text: >-
we uncovered a role of ORMDL3 in fine-tuning B cell development and
survival, besides highlighting a potential mechanism by which ORMDL3
regulates autophagy via ATF6 pathway
# --- Reactome TAS annotations ---
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6798743
review:
summary: >-
Reactome annotation placing ORMDL3 at the plasma membrane based on
neutrophil degranulation pathway. ORMDL3 is an ER-resident protein with
no experimental evidence for plasma membrane localization. The original
discovery paper (PMID:12093374) explicitly showed no colocalization with
plasma membrane markers.
action: REMOVE
reason: >-
ORMDL3 is established as an ER-resident multi-pass transmembrane protein.
Hjelmqvist et al. 2002 showed that EGFP-ORMDL3 colocalizes with the ER
marker PDI but showed no overlapping signal with plasma membrane marker
concanavalin A. The Reactome pathway for neutrophil degranulation may
include ORMDL3 based on proteomics of secretory granule fractions, but
this does not represent the functional localization of ORMDL3.
supported_by:
- reference_id: PMID:12093374
supporting_text: >-
double-label fluorescence with biotin-labeled concanavalin A... showed
no overlapping signal with EGFP-ORMDL at the plasmatic membrane
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6799350
review:
summary: >-
Second Reactome annotation to plasma membrane from specific granule
exocytosis pathway. Same issue as above.
action: REMOVE
reason: >-
No experimental evidence supports plasma membrane localization of ORMDL3.
ORMDL3 is firmly established as an ER membrane protein by GFP-fusion,
immunofluorescence, and cryo-EM structural studies.
- term:
id: GO:0030667
label: secretory granule membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6798743
review:
summary: >-
Reactome annotation placing ORMDL3 in secretory granule membranes from
the neutrophil degranulation pathway. While ORMDL3 may have been detected
in proteomics of granule fractions, its established function and
localization is in the ER as part of the SPT complex.
action: REMOVE
reason: >-
ORMDL3's confirmed localization and functional site is the ER membrane.
Detection in granule proteomic fractions may reflect ER contamination or
transit through the secretory pathway, not a functional localization.
- term:
id: GO:0035579
label: specific granule membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6799350
review:
summary: >-
Reactome annotation to specific granule membrane from neutrophil-specific
granule exocytosis pathway. Same concern as secretory granule membrane.
action: REMOVE
reason: >-
No functional evidence supports ORMDL3 localization to specific granule
membranes. This likely arises from proteomic detection in granule
fractions that may include ER membrane contaminants.
# --- IDA/IMP annotations from PMID:25691431 (Siow et al. 2015) ---
- term:
id: GO:0017059
label: serine palmitoyltransferase complex
evidence_type: IDA
original_reference_id: PMID:25691431
review:
summary: >-
Siow et al. 2015 demonstrated that ORMDLs and SPT form stable complexes
in human bronchial epithelial cells (HBECs) and HeLa cells, and that
ORMDL is expressed in functional excess relative to SPT. Direct
experimental evidence for SPT complex membership.
action: ACCEPT
reason: >-
Core localization. Direct biochemical evidence for ORMDL3 as a component
of the SPT complex in human cells.
supported_by:
- reference_id: PMID:25691431
supporting_text: >-
ORMDLs and SPT form stable complexes that are not increased by elevated
ORMDL3 expression
- term:
id: GO:1900060
label: negative regulation of ceramide biosynthetic process
evidence_type: IMP
original_reference_id: PMID:25691431
review:
summary: >-
Siow et al. 2015 showed that ORMDL3 negatively regulates ceramide
biosynthesis, though the relationship is complex due to ORMDL
stoichiometry with SPT. At normal expression levels, ORMDL is in
functional excess over SPT, meaning additional ORMDL3 does not further
suppress biosynthesis.
action: ACCEPT
reason: >-
Core function. ORMDL3's role as a negative regulator of ceramide
biosynthesis (via SPT inhibition) is well established. This is the most
specific biological process term available for ORMDL3's primary function.
supported_by:
- reference_id: PMID:25691431
supporting_text: >-
The ORM1 (Saccharomyces cerevisiae)-like proteins (ORMDLs) and their
yeast orthologs, the Orms, are negative homeostatic regulators of the
initiating enzyme in sphingolipid biosynthesis, serine
palmitoyltransferase (SPT)
# --- IDA annotations from PMID:12093374 and PMID:20182505 ---
- term:
id: GO:0005783
label: endoplasmic reticulum
evidence_type: IDA
original_reference_id: PMID:12093374
review:
summary: >-
Original characterization of the ORMDL gene family by Hjelmqvist et al.
2002. GFP-ORMDL3 fusion protein colocalized with the ER marker PDI in
COS-7 cells by confocal microscopy, establishing ER localization.
action: ACCEPT
reason: >-
Primary experimental evidence for ER localization of ORMDL3. This is the
foundational study establishing the subcellular localization of the ORMDL
protein family.
supported_by:
- reference_id: PMID:12093374
supporting_text: >-
Confocal scanning microscopy using an antibody against
protein-disulfide isomerase (PDI), an ER-marker protein, showed an
overlapping signal in the endoplasmic reticulum... these data show that
the ORMDL proteins locate at the ER membrane
- term:
id: GO:0006672
label: ceramide metabolic process
evidence_type: IMP
original_reference_id: PMID:20182505
review:
summary: >-
Breslow et al. 2010 demonstrated that simultaneous RNAi knockdown of
ORMDL1/2/3 in HeLa cells causes approximately three-fold increase in
ceramide levels. This landmark study established the role of ORM/ORMDL
proteins in sphingolipid homeostasis.
action: ACCEPT
reason: >-
Core function. Direct experimental evidence that ORMDL proteins regulate
ceramide levels in human cells.
supported_by:
- reference_id: PMID:20182505
supporting_text: >-
we found that simultaneous knock-down by RNAi of ORMDL1/2/3 in Hela
cells causes an approximately three-fold increase in ceramide levels
- term:
id: GO:0017059
label: serine palmitoyltransferase complex
evidence_type: IDA
original_reference_id: PMID:20182505
review:
summary: >-
Breslow et al. 2010 showed that Flag-tagged ORMDL3 co-immunoprecipitates
with SPTLC1 from HEK293T cells, demonstrating the conserved physical
association between ORMDL3 and the SPT complex in human cells.
action: ACCEPT
reason: >-
Core localization. Direct co-IP evidence for ORMDL3 as a component of
the SPT complex in human cells, confirmed by subsequent cryo-EM
structures.
supported_by:
- reference_id: PMID:20182505
supporting_text: >-
Immunoprecipitations from HEK293T cells expressing 3×Flag-tagged Ormdl3
led to a prominent Sptlc1 band detected by Western blot (Fig
# --- NEW annotations suggested ---
- term:
id: GO:0004857
label: enzyme inhibitor activity
evidence_type: IDA
original_reference_id: PMID:33558761
review:
summary: >-
ORMDL3 functions as a direct inhibitor of the SPT enzyme by physically
occluding the substrate entry tunnel through its N-terminus. Cryo-EM
structures at 2.6 Angstrom resolution show that ORMDL3 blocks the
substrate-binding tunnel and competes with substrate binding. This is the
primary molecular function of ORMDL3.
action: NEW
reason: >-
ORMDL3 has no MF annotation other than the uninformative protein binding.
The structural and biochemical evidence clearly demonstrates that ORMDL3
functions as an enzyme inhibitor of SPT. This is the core molecular
function of the protein.
supported_by:
- reference_id: PMID:33558761
supporting_text: >-
ORMDL3 blocks the tunnel and competes with substrate binding through
its amino terminus
- reference_id: PMID:20182505
supporting_text: >-
we identify Orm proteins as negative regulators of sphingolipid
synthesis that form a conserved complex with serine
palmitoyltransferase, the first and rate-limiting enzyme in
sphingolipid production
- term:
id: GO:0097001
label: ceramide binding
evidence_type: IDA
original_reference_id: PMID:37308477
review:
summary: >-
Xie et al. 2023 demonstrated that ceramide binds to the N-terminus of
ORMDL3, stabilizing an inhibitory conformation. Key residue Asn13 is
critical for ceramide binding; N13A mutation disrupts ceramide
responsiveness. Cryo-EM structures resolved the ceramide-bound SPT-ORMDL3
complex.
action: NEW
reason: >-
Ceramide binding is a critical molecular function of ORMDL3 that enables
the homeostatic feedback loop. This is structurally and mutagenetically
validated and represents a genuine molecular function annotation.
additional_reference_ids:
- PMID:37308477
supported_by:
- reference_id: PMID:37308477
supporting_text: >-
purified human SPT-ORMDL complexes are inhibited by the central
sphingolipid metabolite ceramide. We have solved the cryo-EM structure
of the SPT-ORMDL3 complex in a ceramide-bound state. Structure-guided
mutational analyses reveal the essential function of this ceramide
binding site for the suppression of SPT activity.
- term:
id: GO:0090155
label: negative regulation of sphingolipid biosynthetic process
evidence_type: IMP
original_reference_id: PMID:20182505
review:
summary: >-
Breslow et al. 2010 established that ORM/ORMDL proteins are negative
regulators of sphingolipid biosynthesis. RNAi knockdown of all three
ORMDL genes in HeLa cells increased ceramide levels three-fold,
demonstrating the negative regulatory role. This term captures the
specific directionality of ORMDL3's regulatory function better than the
more general terms currently annotated.
action: NEW
reason: >-
This term specifically captures ORMDL3's role as a negative regulator of
sphingolipid biosynthesis, which is more precise than the existing
GO:0030148 (sphingolipid biosynthetic process) annotation. The current
GO annotations lack a biological process term that specifies the negative
regulatory direction.
supported_by:
- reference_id: PMID:20182505
supporting_text: >-
we identify Orm proteins as negative regulators of sphingolipid
synthesis that form a conserved complex with serine
palmitoyltransferase
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with
GO terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning
models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:12093374
title: ORMDL proteins are a conserved new family of endoplasmic reticulum
membrane proteins.
findings:
- statement: >-
ORMDL3 encodes a 153 amino acid ER-resident transmembrane protein.
GFP-ORMDL3 colocalizes with ER marker PDI but not with plasma membrane
marker concanavalin A in COS-7 cells. Human ORMDL3 can rescue yeast
orm1/orm2 double knockout phenotypes, demonstrating functional
conservation.
supporting_text: >-
Confocal scanning microscopy using an antibody against protein-disulfide
isomerase (PDI), an ER-marker protein, showed an overlapping signal in
the endoplasmic reticulum
- id: PMID:20182505
title: Orm family proteins mediate sphingolipid homeostasis.
findings:
- statement: >-
Landmark study identifying ORM/ORMDL proteins as negative regulators of
SPT that form a conserved complex (SPOTS complex) with SPT and Sac1.
ORMDL3 co-immunoprecipitates with SPTLC1 in human HEK293T cells.
Triple RNAi knockdown of ORMDL1/2/3 in HeLa cells increases ceramide
levels ~3-fold.
supporting_text: >-
we found that simultaneous knock-down by RNAi of ORMDL1/2/3 in Hela
cells causes an approximately three-fold increase in ceramide levels
- id: PMID:25691431
title: ORMDL/serine palmitoyltransferase stoichiometry determines effects of
ORMDL3 expression on sphingolipid biosynthesis.
findings:
- statement: >-
ORMDLs and SPT form stable complexes in human cells. ORMDL is normally
expressed in functional excess relative to SPT, meaning ORMDL3
overexpression does not further suppress biosynthesis. The relationship
between ORMDL3 expression and sphingolipid levels is complex and
stoichiometry-dependent.
supporting_text: >-
We determined that ORMDL is expressed in functional excess relative to
SPT at normal levels of expression. ORMDLs and SPT form stable complexes
that are not increased by elevated ORMDL3 expression.
- id: PMID:28747345
title: "ORMDL3 Facilitates the Survival of Splenic B Cells via an ATF6α-Endoplasmic
Reticulum Stress-Beclin1 Autophagy Regulatory Pathway."
findings:
- statement: >-
ORMDL3 knockout in mice decreases mature B cells, increases splenic B cell
apoptosis, and reduces autophagy. ORMDL3 promotes B cell survival via
ATF6-Beclin1 autophagy pathway. These are likely downstream effects of
altered sphingolipid metabolism and ER stress.
supporting_text: >-
silencing Ormdl3 in vivo significantly decreased the proportions of
mature B lymphocytes and transitional 2B cells in spleen
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings:
- statement: >-
High-throughput binary protein interactome mapping study (HuRI). Reports
many ORMDL3 interactors but most are unvalidated membrane protein
interactions from yeast two-hybrid screens.
supporting_text: >-
Here we present a human 'all-by-all' reference interactome map of human
binary protein interactions, or 'HuRI'. With approximately 53,000
protein-protein interactions
- id: PMID:33558761
title: Structural insights into the regulation of human serine
palmitoyltransferase complexes.
findings:
- statement: >-
Cryo-EM structures of the human SPT-ORMDL3 complex at 2.6-3.4 Angstrom
resolution. Reveals that ORMDL3 blocks the SPT substrate-binding tunnel
through its N-terminus, competing with substrate binding. ssSPTa shapes
the tunnel to determine substrate specificity.
supporting_text: >-
ORMDL3 blocks the tunnel and competes with substrate binding through
its amino terminus
- id: PMID:33558762
title: Structural insights into the assembly and substrate selectivity of
human SPT-ORMDL3 complex.
findings:
- statement: >-
Independent cryo-EM structures of the human SPT-ORMDL3 complex at 3.2
Angstrom resolution confirming the four-transmembrane topology of ORMDL3
and its integration within the SPT holoenzyme.
supporting_text: >-
ORMDL3 is located in the center of the complex, serving to stabilize
the SPT assembly
- id: PMID:37308477
title: Ceramide sensing by human SPT-ORMDL complex for establishing
sphingolipid homeostasis.
findings:
- statement: >-
Cryo-EM structures and mutagenesis demonstrating that ceramide binds to
the ORMDL3 N-terminus and stabilizes the inhibitory conformation that
blocks SPT activity. Key residue Asn13 is essential for ceramide sensing.
supporting_text: >-
Structural studies indicate that ceramide can induce and lock the
N-terminus of ORMDL3 into an inhibitory conformation.
- id: PMID:30700557
title: "The ORMDL/Orm-serine palmitoyltransferase (SPT) complex is directly regulated by ceramide: Reconstitution of SPT regulation in isolated membranes."
findings:
- statement: >-
Reconstitution of SPT regulation in isolated membranes demonstrates that
ceramide directly regulates the ORMDL/SPT complex, providing biochemical
evidence for the ceramide feedback mechanism.
supporting_text: >-
Sphingolipid and ORMDL-dependent regulation of SPT was demonstrated in
isolated membranes, essentially free of cytosol. This suggests that this
regulation does not require soluble cytosolic proteins or small molecules
such as ATP. We found that this system is particularly responsive to the
pro-apoptotic sphingolipid ceramide
- id: Reactome:R-HSA-6798743
title: Exocytosis of secretory granule membrane proteins
findings: []
- id: Reactome:R-HSA-6799350
title: Exocytosis of specific granule membrane proteins
findings: []
- id: file:human/ORMDL3/ORMDL3-deep-research-falcon.md
title: Deep research review of ORMDL3 function
findings:
- statement: >-
Comprehensive literature review covering ORMDL3 as ER-resident SPT
regulator, ceramide-dependent feedback mechanism, roles in asthma,
immune cell biology, ER stress/UPR, and innate immunity.
core_functions:
- description: >-
Negative regulation of serine palmitoyltransferase (SPT) activity as a
ceramide-sensitive regulatory subunit of the SPT holoenzyme complex.
ORMDL3 physically occludes the SPT substrate entry tunnel through its
N-terminus, competing with substrate binding (PMID:33558761). Ceramide
binding to the ORMDL3 N-terminus (Asn13-dependent) stabilizes this
inhibitory conformation, implementing homeostatic feedback control of
de novo sphingolipid biosynthesis (PMID:37308477).
molecular_function:
id: GO:0004857
label: enzyme inhibitor activity
supported_by:
- reference_id: PMID:20182505
supporting_text: >-
we identify Orm proteins as negative regulators of sphingolipid
synthesis that form a conserved complex with serine
palmitoyltransferase, the first and rate-limiting enzyme in
sphingolipid production
- reference_id: PMID:33558761
supporting_text: >-
ORMDL3 blocks the tunnel and competes with substrate binding through
its amino terminus
- reference_id: PMID:37308477
supporting_text: >-
Ceramide sensing by human SPT-ORMDL complex for establishing
sphingolipid homeostasis
- description: >-
Ceramide binding at the N-terminus enabling homeostatic feedback
regulation of sphingolipid de novo biosynthesis. ORMDL3 senses
cellular ceramide levels and translates this into inhibition of SPT
activity. Asn13 is a critical residue for ceramide sensing
(PMID:37308477). This molecular sensing function is integral to the
sphingolipid homeostatic feedback loop.
molecular_function:
id: GO:0097001
label: ceramide binding
supported_by:
- reference_id: PMID:37308477
supporting_text: >-
Structural studies indicate that ceramide can induce and lock the
N-terminus of ORMDL3 into an inhibitory conformation.
- reference_id: PMID:30700557
supporting_text: >-
The ORMDL/Orm-serine palmitoyltransferase (SPT) complex is directly
regulated by ceramide [reconstitution demonstrates direct ceramide
regulation of the ORMDL/SPT complex]
full_text_unavailable: true